Related Experiment Video

Updated: Jul 7, 2026

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery
08:38

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Published on: August 16, 2019

Two models of homocysteine behavior in acute myocardial infarction

Alvaro Osorio1, Esperanza Ortega, Estrella Ruiz-Requena

  • 1Department of Cardiovascular Surgery, La Princesa University Hospital s/n, Madrid, Spain.

Clinical Biochemistry
|February 1, 2008
PubMed

Insights

Homocysteine (Hcy) levels in myocardial infarction (MI) patients show distinct patterns post-infarction. Some patients exhibit rising Hcy, while others show decreasing levels, potentially indicating asymptomatic myocardial ischemia.

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Medicine

Background:

  • Elevated homocysteine (Hcy) is a risk factor for cardiovascular diseases.
  • Understanding Hcy dynamics post-myocardial infarction (MI) is crucial for patient management.

Purpose of the Study:

  • To investigate homocysteine (Hcy) levels in patients during the post-myocardial infarction (MI) follow-up period.
  • To compare Hcy levels between MI patients and healthy controls.

Main Methods:

  • Serum Hcy levels were measured in 127 acute MI patients on day 0 and days 2, 5, 7, 9, and 11 post-infarction.
  • Hcy levels were compared between MI patients and 90 healthy controls.
  • MI patients were categorized based on day 0 Hcy levels relative to controls.

Main Results:

  • Acute MI patients exhibited higher Hcy levels on day 0 compared to controls.
  • Two distinct Hcy patterns were observed in MI patients post-infarction.
  • One group showed increased Hcy levels from day 2 onwards, while another group displayed decreased levels from day 0.

Conclusions:

  • The differing Hcy level behaviors in MI patients may correlate with the presence or absence of asymptomatic myocardial ischemia.
  • Further research is warranted to validate the association between Hcy dynamics and asymptomatic myocardial ischemia.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...